Félix Omeñaca - Concepedia

Author

Félix Omeñaca

Also Known As

Ana Concheiro-Guisan, Enrique Bernaola Iturbe, FELIX OMEÑACA, Felix Omenaca, Felix Omeñaca, Felix Omeñaca, Félix Omeñaca, Omeñaca Félix, Omeñaca, Felix

Publications

863

Citations

H-Index

Concepts

All Affiliations

Hospital Universitario La Paz Hospital Universitario de Móstoles GlaxoSmithKline (Belgium)Hospital General Yagüe GlaxoSmithKline (Spain)

About

Félix Omeñaca is an author at Hospital Universitario La Paz specializing in medicine, infection control, and vaccine development.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	157
2	Immunology	2	2	135
3	Public Health	1	1	37
4	Epidemiology	1	1	37
5	Clinical Epidemiology	1	1	37

Félix Omeñaca

Publications

733

Citations

H-Index

Page 1

	Year	Citations
Immunogenicity and safety of AS03-adjuvanted 2009 influenza A H1N1 vaccine in children 6–35 months Alfonso Carmona, Félix Omeñaca, Juan Carlos Tejedor Torres, Vaccine VaccinationVaccine SafetyVaccinologyVaccine DevelopmentMedicine	2010	94
Neonatal early onset Escherichia coli sepsis: trends in incidence and antimicrobial resistance in the era of intrapartum antimicrobial prophylaxis Ana Alarcón, Pilar Peña, Sofía P. Salas, The Pediatric Infectious Disease Journal	2004	85
Response of Preterm Newborns to Immunization With a Hexavalent Diphtheria–Tetanus–Acellular Pertussis–Hepatitis B Virus–Inactivated Polio and<i>Haemophilus influenzae</i>Type b Vaccine: First Experiences and Solutions to a Serious and Sensitive Issue Félix Omeñaca, José García-Sicilia, Pilar Garcı́a-Corbeira, PEDIATRICS	2005	85
Safety, Reactogenicity and Immunogenicity of the Human Rotavirus Vaccine in Preterm European Infants Félix Omeñaca, J Sarlangue, Leszek Szenborn, The Pediatric Infectious Disease Journal	2012	64
Immunization of Preterm Infants With 10-Valent Pneumococcal Conjugate Vaccine Félix Omeñaca, José Merino, Juan Carlos Tejedor Torres, PEDIATRICS	2011	41
Immunogenicity and Reactogenicity of a Three-Dose Primary Vaccination Course With a Combined Diphtheria-Tetanus-Acellular Pertussis-Hepatitis B-Inactivated Polio-Haemophilus influenzae Type b Vaccine Coadministered With a Meningococcal C Conjugate Vaccine Juan Carlos Tejedor Torres, Félix Omeñaca, José García-Sicilia, The Pediatric Infectious Disease Journal VaccinationVaccine SafetyVaccinologyInfanrix HexaInfectious Disease Prevention	2004	41
Serratia marcescens outbreak in a neonatology unit of a Spanish tertiary hospital: Risk factors and control measures Lidia Redondo-Bravo, Enrique Gutiérrez‐González, Isabel San Juan-Sanz, American Journal of Infection Control Neonatology UnitHealthcare-associated InfectionClinical EpidemiologyDisease OutbreakInfection Control	2018	37
Antibody Persistence and Booster Vaccination During the Second and Fifth Years of Life in a Cohort of Children Who Were Born Prematurely Félix Omeñaca, José García-Sicilia, Reyes Boceta, The Pediatric Infectious Disease Journal	2007	36
Antipolyribosyl Ribitol Phosphate Response of Premature Infants to Primary and Booster Vaccination With a Combined Diphtheria-Tetanus-Acellular Pertussis-Hepatitis B-Inactivated Polio Virus/<i>Haemophilus influenzae</i>Type b Vaccine Félix Omeñaca, José García-Sicilia, Pilar Garcı́a-Corbeira, PEDIATRICS	2006	33
Evaluation of cytomegalovirus infection in low-birth weight children by breast milk using a real-time polymerase chain reaction assay Romero-Gómez Maria Pilar, Cabrera Marta, Montes-Bueno María Teresa, Journal of Medical Virology	2015	30

Page 1